Cargando…

Risk Assessment of Endometrial Hyperplasia or Endometrial Cancer with Simplified Ultrasound-Based Scoring Systems

Background: Abnormal uterine bleeding (AUB) represents a common diagnostic challenge, as it might be related to both benign and malignant conditions. Endometrial cancer may not be detected with blind uterine cavity sampling by dilatation and curettage or suction devices. Several scoring systems usin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stachowicz, Norbert, Smoleń, Agata, Ciebiera, Michał, Łoziński, Tomasz, Poziemski, Paweł, Borowski, Dariusz, Czekierdowski, Artur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001089/ https://www.ncbi.nlm.nih.gov/pubmed/33806571 http://dx.doi.org/10.3390/diagnostics11030442

Ejemplares similares

Sonographic Assessment of Complex Ultrasound Morphology Adnexal Tumors in Pregnant Women with the Use of IOTA Simple Rules Risk and ADNEX Scoring Systems
por: Czekierdowski, Artur, et al.
Publicado: (2021)

Performance of IOTA Simple Rules Risks, ADNEX Model, Subjective Assessment Compared to CA125 and HE4 with ROMA Algorithm in Discriminating between Benign, Borderline and Stage I Malignant Adnexal Lesions
por: Czekierdowski, Artur, et al.
Publicado: (2023)

Tumor budding index and microvessel density assessment in patients with endometrial cancer: A pilot study
por: Kluz, Tomasz, et al.
Publicado: (2020)

Magnetic Resonance-Guided High-Intensity Focused Ultrasound Ablation of Uterine Fibroids—Efficiency Assessment with the Use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging and the Potential Role of the Administration of Uterotonic Drugs
por: Łoziński, Tomasz, et al.
Publicado: (2021)

The Role of miRNA and Related Pathways in Pathophysiology of Uterine Fibroids—From Bench to Bedside
por: Ciebiera, Michał, et al.
Publicado: (2020)

The role of magnetic resonance-guided focused ultrasound in fertility-sparing treatment of uterine fibroids—current perspectives
por: Ciebiera, Michał, et al.
Publicado: (2020)

Genomic imbalance in endometrial hyperplasia and cancer
por: Bednarek, Michal, et al.
Publicado: (2015)

Diagnostic Accuracy of Hysteroscopic Scoring System in Predicting Endometrial Malignancy and Atypical Endometrial Hyperplasia
por: Harika, Bhukya, et al.
Publicado: (2021)

Endometrial hyperplasia as a risk factor of endometrial cancer
por: Nees, Lisa K., et al.
Publicado: (2022)

Occurrence and Risk Factors for Perioperative Treatment Discontinuation during Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MR-HIFU) Therapy in Symptomatic Uterine Fibroids—A Retrospective Case–Control Study
por: Kociuba, Jakub, et al.
Publicado: (2023)

Expression of the VEGF and angiopoietin genes in endometrial atypical hyperplasia and endometrial cancer
por: Holland, C M, et al.
Publicado: (2003)

PTEN Sequence Analysis in Endometrial Hyperplasia and Endometrial Carcinoma in Slovak Women
por: Gbelcová, H., et al.
Publicado: (2015)

Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma
por: Lv, Mu, et al.
Publicado: (2022)

Rapid identification of endometrial hyperplasia and endometrial endometrioid cancer in young women
por: Kuai, Dan, et al.
Publicado: (2023)

Assessment of endometrial receptor systems for PPPM approach for endometrial hyperplasia in reproductive age women
por: Goncharenko, Vadym M, et al.
Publicado: (2014)

Endometrial Stromal Hyperplasia: An Underrecognized Condition
por: Sivridis, Efthimios, et al.
Publicado: (2013)

Therapeutic options for management of endometrial hyperplasia
por: Chandra, Vishal, et al.
Publicado: (2016)

Quantitative contrast-enhanced ultrasonography for the differential diagnosis of endometrial hyperplasia and endometrial neoplasms
por: Liu, Ying, et al.
Publicado: (2016)

Risk factors of endometrial cancer in patients with endometrial hyperplasia: implication for clinical treatments
por: Zhao, Jie, et al.
Publicado: (2021)

Fertility-Sparing Treatment for Endometrial Cancer or Atypical Endometrial Hyperplasia Patients With Obesity
por: Chen, Junyu, et al.
Publicado: (2022)

Laparoscopic Surgery for Atypical Endometrial Hyperplasia with Awareness Regarding the Possibility of Endometrial Cancer
por: Kamii, Misato, et al.
Publicado: (2022)

Association of the Apolipoprotein E 2 Allele with Concurrent Occurrence of Endometrial Hyperplasia and Endometrial Carcinoma
por: Ivanova, Tatiana I., et al.
Publicado: (2015)

Endometrial evaluation with transvaginal ultrasonography for the screening of endometrial hyperplasia or cancer in premenopausal and perimenopausal women
por: Kim, Min-Jeong, et al.
Publicado: (2016)

Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women
por: Uccella, Stefano, et al.
Publicado: (2022)

Value of endometrial thickness for the detection of endometrial cancer and atypical hyperplasia in asymptomatic postmenopausal women
por: Zhang, Linna, et al.
Publicado: (2022)

Metformin for endometrial hyperplasia: a Cochrane protocol
por: Clement, Naomi S, et al.
Publicado: (2016)

Lymph node dissection in atypical endometrial hyperplasia
por: Taşkın, Salih, et al.
Publicado: (2017)

The value of MRI in management of endometrial hyperplasia with atypia
por: Natarajan, Purushothaman, et al.
Publicado: (2020)

The Value of Vaginal Microbiome in Patients with Endometrial Hyperplasia
por: Zhang, Hu, et al.
Publicado: (2021)

Correlation of Metabolic Factors with Endometrial Atypical Hyperplasia and Endometrial Cancer: Development and Assessment of a New Predictive Nomogram
por: Zhang, He, et al.
Publicado: (2021)

Personalized treatment strategy for atypical endometrial hyperplasia with regards to age, comorbidities and endometrial receptor status
por: Goncharenko, Vadym M, et al.
Publicado: (2014)

The incidence rates of endometrial hyperplasia and endometrial cancer: a four-year population-based study
por: Yuk, Jin-Sung
Publicado: (2016)

Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia
por: Matsuzaki, Toshiya, et al.
Publicado: (2018)

Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management
por: Nwanodi, Oroma
Publicado: (2017)

miRNAs as Candidate Biomarker for the Accurate Detection of Atypical Endometrial Hyperplasia/Endometrial Intraepithelial Neoplasia
por: Giglio, Simona, et al.
Publicado: (2019)

Risk factors of progression to endometrial cancer in women with endometrial hyperplasia: A retrospective cohort study
por: Jeong, Jin Young, et al.
Publicado: (2020)

Endometrial Metaplastic/Reactive Changes Coexistent with Endometrial Hyperplasia and Carcinoma: A Morphological and Immunohistochemical Study
por: Travaglino, Antonio, et al.
Publicado: (2021)

The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer
por: Guan, Jun, et al.
Publicado: (2022)

Atypical Endometrial Hyperplasia Arising in a Cesarean Section Scar: A Mechanism of Malignant Transformation
por: Monist, Marta, et al.
Publicado: (2019)

Application of ultrasound multimodal score in the assessment of endometrial receptivity in patients with artificial abortion
por: Jiao, Yan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5s9f3blaoqnvaku3bqbj0qeqah